CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2006-02-06): Cyclosporine shows anti-HCV activity in vitro and in liver transplant recipients

Science

Cyclosporine shows anti-HCV activity in vitro and in liver transplant recipients

Last Updated: 2006-02-06 8:44:16 -0400 (Reuters Health)

NEW YORK (Reuters Health) - The immunosuppressive agent cyclosporine is active against hepatitis C virus (HCV) in vitro and its use can improve the chances of a sustained virologic response in HCV-infected liver transplant recipients, new research shows.

In previous studies, cyclosporine has shown activity against HIV, herpes simplex, and vaccinia viruses, according to the report in the January issue of Liver Transplantation. Now, Dr. Roberto J. Firbi, from the University of Florida in Gainesville, and colleagues evaluated the drug's ability to clear HCV in liver transplant recipients treated with interferon and ribavirin for 48 weeks after progressive histologic disease was identified.

The retrospective analysis involved 56 patients who were treated with a cyclosporine-based immunosuppressive regimen and 59 treated with one based on tacrolimus.

The sustained virologic response rate in the cyclosporine group was 46%, much higher than the 27% rate noted in the tacrolimus group (p = 0.03).

In vitro analysis showed that cyclosporine inhibited HCV replication in a dose-dependent fashion. Moreover, the mechanism involved is distinct from that used by interferon and an additive effect was seen when both drugs were given together.

"HCV infection is of major concern after liver transplantation due to universal recurrence, more rapid fibrosis progression, and potential graft failure," the authors state. The present findings suggest that cyclosporine is better than tacrolimus at halting HCV replication, but confirmation in randomized controlled trials is needed.

Liver Transpl 2006;12:51-57.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.